During the past decade, McDowell Cancer Center at Akron General Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 45 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McDowell Cancer Center at Akron General Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 28 trials, followed by "Radiation Therapy Oncology Group" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "NSABP Foundation Inc" with 8 trials sponsored and "Gynecologic Oncology Group" with 8 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McDowell Cancer Center at Akron General Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "McDowell Cancer Center at Akron General Medical Center" are "Breast Cancer" (20 trials), "Lung Cancer" (14 trials), "Prostate Cancer" (10 trials), "Colorectal Cancer" (6 trials) and "Esophageal Cancer" (6 trials). Many other conditions were trialed in "McDowell Cancer Center at Akron General Medical Center" in a lesser frequency.

Most popular intervention types in "McDowell Cancer Center at Akron General Medical Center" are "Drug" (66 trials), "Radiation" (38 trials), "Other" (21 trials), "Biological" (18 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (19 trials), "cisplatin" (14 trials), "placebo" (10 trials), "cetuximab" (9 trials) and "paclitaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "McDowell Cancer Center at Akron General Medical Center" are 61 trials for "All" genders, 19 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "McDowell Cancer Center at Akron General Medical Center". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 70 completed trials in McDowell Cancer Center at Akron General Medical Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in McDowell Cancer Center at Akron General Medical Center, 2 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".